Ajanta Pharma Limited EBIT for the year ending March 31, 2025: USD 131.56 M

Ajanta Pharma Limited EBIT is USD 131.56 M for the year ending March 31, 2025, a -2.13% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Ajanta Pharma Limited EBIT for the year ending March 31, 2024 was USD 134.41 M, a 47.08% change year over year.
  • Ajanta Pharma Limited EBIT for the year ending March 31, 2023 was USD 91.39 M, a -24.55% change year over year.
  • Ajanta Pharma Limited EBIT for the year ending March 31, 2022 was USD 121.12 M, a -2.37% change year over year.
  • Ajanta Pharma Limited EBIT for the year ending March 31, 2021 was USD 124.07 M, a 38.33% change year over year.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)